Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Redmile Group, LLC | 14.55M | $80.0M | 7.49% | +4.50M | 2026-03-31 |
| BlackRock, Inc. | 10.94M | $60.0M | 5.63% | +1.98M | 2026-03-31 |
| FMR LLC | 10.64M | $58.0M | 5.48% | +413.2K | 2026-03-31 |
| BVF INC/IL | 8.70M | $48.0M | 4.48% | -429.9K | 2026-03-31 |
| STATE STREET CORP | 6.92M | $38.0M | 3.56% | +2.27M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.96M | $32.0M | 3.07% | -- | 2026-03-31 |
| Bain Capital Life Sciences Investors, LLC | 5.21M | $28.0M | 2.68% | -36.4K | 2026-03-31 |
| Bellevue Group AG | 5.16M | $28.0M | 2.66% | -- | 2026-03-31 |
| MAK CAPITAL ONE LLC | 4.72M | $26.0M | 2.43% | +1.77M | 2026-03-31 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4.30M | $23.0M | 2.21% | -1.20M | 2026-03-31 |
